.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Avexia's performance across various states and categories presents a mixed picture, with notable strengths and some areas for improvement. In Illinois, Avexia has consistently held the top spot in the Topical category from August to November 2025, indicating a strong market presence and consumer preference. However, their ranking in the Concentrates category has seen a decline, dropping from 18th in August to 26th by November, which may suggest increased competition or shifting consumer preferences. Meanwhile, in Maryland, Avexia's performance in the Capsules category has been relatively stable, maintaining a top-three position, although they briefly slipped to third place in October before regaining second place in November.
In New Jersey, Avexia has shown strong performance in the Topical category, consistently ranking first or second throughout the observed months. Their performance in Concentrates has been steady, remaining in the 11th to 13th range, which indicates a stable but less dominant presence. However, their absence from the top 30 in the Tincture & Sublingual category after being ranked fourth in September suggests a potential decline in market share or a strategic shift away from this category. In Ohio, Avexia's rankings in the Tincture & Sublingual category have slipped slightly, moving from third to fourth place by November, highlighting a need for strategic attention to regain their earlier momentum.
Competitive Landscape
In the Illinois Topical category, Avexia has consistently maintained its top position from August to November 2025, indicating a strong market presence and customer loyalty. Despite a slight dip in sales in October, Avexia's sales rebounded in November, showcasing resilience and effective market strategies. In contrast, Doctor Solomon's has held the second rank throughout the same period, but its sales figures have fluctuated more significantly, particularly with a decline in November, which could suggest challenges in sustaining consumer interest or competitive pricing. Meanwhile, Alchemy (Ieso) has consistently ranked fourth, except for October when it fell out of the top 20, indicating potential volatility in its market performance. These dynamics highlight Avexia's robust positioning and suggest that it is well-equipped to capitalize on any market shifts or competitive weaknesses.
Notable Products
In November 2025, Avexia's top-performing product was the CBD/THC 1:1 Harmony Pain Relief Balm (100mg CBD, 100mg THC, 2oz) in the Topical category, maintaining its number one rank for four consecutive months with sales of 8,847 units. The CBD/THC 4:1 Relief Tablets 40-Pack (400mg CBD, 100mg THC) held steady at the second rank, showing consistent performance in the Capsules category. Similarly, the CBN/CBD/THC 1:1:1 Comfort Tablets 40-Pack (100mg CBN, 100mg CBD, 100mg THC) remained in third place, indicating stable demand. The CBD/THC 1:1 Harmony Micro-Dosed Tablets 40-Pack (100mg CBD,100mg THC) and the CBG/THC 1:1 Ascend Tablets 40-Pack (100mg CBG, 100mg THC) also retained their fourth and fifth positions respectively, demonstrating a steady sales trend across these products. Overall, the rankings for Avexia's top products remained unchanged from the previous months, reflecting consistent consumer preference and product performance.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
